|
Clinicopathological parameters
|
Number
|
MTSS1/GAPDH mRNA (n)
|
P
|
|---|
|
MTSS1-low group
|
MTSS1-high group
|
|---|
|
(≤0.18, n = 17)
|
(>0.18, n = 20)
|
|---|
|
Age
|
37
| | |
0.900
|
|
≤ 52 y
|
20
|
9
|
11
| |
|
> 52 y
|
17
|
8
|
9
| |
|
Sex
|
37
| | |
0.588
|
|
Female
|
8
|
3
|
5
| |
|
Male
|
29
|
14
|
15
| |
|
Cirrhosis
|
37
| | |
0.855
|
|
Yes
|
30
|
14
|
16
| |
|
No
|
7
|
3
|
4
| |
|
Tumor number
|
37
| | |
0.035*
|
|
Multiple
|
20
|
6
|
14
| |
|
Single
|
17
|
11
|
6
| |
|
Satellite
|
36a
| | |
0.019*
|
|
Yes
|
15
|
3
|
12
| |
|
No
|
21
|
13
|
8
| |
|
Tumor size, cm
|
37
| | |
0.212
|
|
≤ 5
|
7
|
5
|
2
| |
|
> 5
|
30
|
12
|
18
| |
|
Encapsulation
|
37
| | |
0.008**
|
|
Complete
|
15
|
11
|
4
| |
|
Incomplete or none
|
22
|
6
|
16
| |
|
Vascular invasion
|
36a
| | |
0.042*
|
|
Yes
|
21
|
6
|
15
| |
|
No
|
15
|
11
|
4
| |
|
TNM stage
|
37
| | |
0.033*
|
|
Early stage (II)
|
7
|
6
|
1
| |
|
Advanced stage (III-IVA)
|
30
|
11
|
19
| |
|
AFP level, ng/mL
|
37
| | |
0.036*
|
|
≤ 20
|
11
|
2
|
9
| |
|
> 20
|
26
|
15
|
11
| |
|
γ-Glutamyl transferase, units/L
|
37
| | |
0.134
|
|
≤ 54
|
19
|
11
|
8
| |
|
> 54
|
18
|
6
|
12
| |
|
Adjuvant TACE
|
37
| | |
0.815
|
|
Yes
|
16
|
7
|
9
| |
|
No
|
21
|
10
|
11
| |
-
NOTE: HCC hepatocellular carcinoma, TACE transcatheter arterial chemoembolization
- Significant difference: * < 0.05, ** < 0.01
-
aNumber less than 37 due to missing data
